Timothy Frances Cloughesy
|MD BA Degree with Honours in chemistry
|Tulane University School of Medicine
Timothy Frances Cloughesy is a professor of Clinical Neurology and director of the Neuro-Oncology Program at the University of California, Los Angeles.He is an expert on the treatment of brain cancer.
He completed his MD at Tulane University School of Medicine in 1987and BA degree with Honors in Chemistry in 1983 at University of California, Santa Barbara. He has an h-index of 119.
The University of California, Los Angeles School of Medicine—known as the David Geffen School of Medicine at UCLA (DGSOM)—is an accredited medical school located in Los Angeles, California, United States. The school was renamed in 2001 in honor of media mogul David Geffen who donated $200 million in unrestricted funds. Founded in 1951, it is the second medical school in the University of California system, after the UCSF School of Medicine.
The UCLA Jonathan and Karin Fielding School of Public Health is the graduate school of public health at UCLA, and is located within the Center for Health Sciences building on UCLA's campus in the Westwood neighborhood of Los Angeles, California. The UCLA Fielding School of Public Health has 690 students representing 25 countries, more than 11,000 alumni and 247 faculty, 70 of whom are full-time.
Robert Peter Gale is an American physician and medical researcher. He is known for research in leukemia and other bone marrow disorders.
Alfredo Quiñones-Hinojosa is a Mexican-American neurosurgeon, author, and researcher. Currently, he is the William J. and Charles H. Mayo Professor and Chair of Neurologic Surgery and runs a basic science research lab at the Mayo Clinic Jacksonville in Florida.
David B. Agus is an American physician and author who serves as a professor of medicine and engineering at the University of Southern California Keck School of Medicine and Viterbi School of Engineering and the Founding Director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine. He is also the cofounder of several personalized medicine companies and a contributor to CBS News on health topics. He is also the author of four books.
The Save A Brain Foundation is a 501(c)(3) non-profit organization with the goals of raising awareness of glioblastoma multiforme (GBM), the most common type of primary brain tumor, as well as raising money in hopes of finding a cure for this terminal disease. To date, the foundation has raised tens of thousands of dollars for brain cancer research.
James S. Economou is an American physician-scientist on the faculty of the University of California, Los Angeles (UCLA) where he is also a surgical oncologist and tumor immunologist. He was Vice Chancellor for Research at UCLA (2010-2015) where he promoted academic entrepreneurship, transdisciplinary research, and support of the humanities, arts, and social sciences. The UCLA research enterprise generates almost one billion dollars in extramural funds annually.
Paul Thompson is a professor of neurology at the Imaging Genetics Center at the University of Southern California. Thompson obtained a bachelor's degree in Greek and Latin languages and mathematics from Oxford University. He also earned a master's degree in mathematics from Oxford and a PhD degree in neuroscience from University of California, Los Angeles.
The Journal of Neuro-Oncology is a peer-reviewed medical journal covering cancer of the central nervous system. It was established in 1983 and is published 15 times per year by Springer Science+Business Media. It was originally published by Martinus Nijhoff Publishers and has been published by Springer since 2005. It is the oldest continuously published journal focused on the field of Neuro-Oncology.
Daniel H. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He also directs the UCLA Neurogenetics Program and the UCLA Center for Autism Research and Treatment (CART), and holds the Gordon and Virginia MacDonald Distinguished Chair of Human Genetics there. Since March 1, 2016, he has served as the Senior Associate Dean and Associate Vice Chancellor for Precision Medicine at UCLA. His brother, Michael Geschwind, is also a professor of neurology, and behavioral neurology pioneer Norman Geschwind is his father's first cousin.
Ashish Suri is an Indian neurosurgeon, medical academic and a professor at the Department of Neurosurgery of the All India Institute of Medical Sciences, Delhi. He was one of the group of surgeons who performed the first 3D brain surgery and the first surgery to implant a spinal cord stimulator in India. Known for his work in Endoscopic endonasal surgery and neurooncology and is a member of the executive committee of the Indian Society of Neuro-Oncology. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development, one of the highest Indian science awards, for his contributions to biosciences, in 2014.
Paul S. Mischel is an American physician-scientist whose laboratory has made pioneering discoveries in the pathogenesis of human cancer. He is currently a Professor and Vice Chair of Research for the Department of Pathology and Institute Scholar of ChEM-H, Stanford University. Mischel was elected into the American Society for Clinical Investigation (ASCI), serving as ASCI president in 2010/11. He was inducted into the Association of American Physicians, and was elected as a fellow of the American Association for the Advancement of Science.
Jonathan Lester Finlay is a pediatric neuro-oncologist specializing in the management of children, adolescents and young adults with brain tumors. He is the director of Neuro-oncology at Nationwide Children's Hospital, where he also serves as the Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer. He also is professor of pediatrics at The Ohio State University College of Medicine.
Linda M. Liau is an American neurosurgeon, neuroscientist, and the W. Eugene Stern Chair of the Department of Neurosurgery at the David Geffen School of Medicine at UCLA. Liau was elected to the Society of Neurological Surgeons in 2013 and the National Academy of Medicine in 2018. She has published over 170 research articles and a textbook, Brain Tumor Immunotherapy. She served as editor-in-chief of the Journal of Neuro-Oncology from 2007 to 2017.
David Hillel Gutmann is an American neurologist. He teaches at Washington University in St. Louis, where he is the Donald O. Schnuck Family Professor, Vice Chair for Research Affairs for the Department of Neurology, and director of the Neurofibromatosis Center at He is an international expert in Neurofibromatosis, pioneering the use of preclinical models to understand brain tumors and neurodevelopmental delays in children with NF1.
Patricia Anne Ganz is an American medical oncologist. She is a professor of health policy and management in the Fielding School of Public Health and a professor of medicine in the David Geffen School of Medicine at UCLA. In 2007, she was elected to the Institute of Medicine.
Beth Young Karlan is an American gynecologic oncologist. In 2008, she was named editor-in-chief of the medical journals Gynecologic Oncology and Gynecologic Oncology Reports. In 2012, Karlan was appointed by the White House to serve on the National Cancer Advisory Board, and in 2015, she was elected to the National Academy of Medicine.
John R. Bentson was an American neuroradiologist who invented the Better Brain-Imaging Tool.
Richard B. Gaynor is an American physician specializing in hematology-oncology, educator, drug developer, and business executive. He served as an Associate Professor of Medicine at UCLA School of Medicine for nearly a decade, and subsequently as an endowed Professor of Medicine and Microbiology at the University of Texas Southwestern Medical School prior to joining the pharmaceutical industry in 2002. His research on NF-κB, IκB kinase, and other mechanisms regulating viral and cellular gene expression has been covered in leading subject reviews. He has been a top executive at several pharmaceutical companies, with respect to the development and clinical testing of novel anticancer drugs and cell therapies. For over a decade and a half, he worked at Eli Lilly and Company, where he became the Senior Vice President of Oncology Clinical Development and Medical Affairs in 2013. Gaynor was President of R&D at Neon Therapeutics from 2016 to 2020, when he became the President of BioNTech US, both pharmaceutical companies headquartered in Cambridge, MA. His honors include being elected a member of the American Society for Clinical Investigation, and the Association of American Physicians.
Michael Albert Thomas is an Indian-American physicist, academic, and clinical researcher. He is a Professor-in-Residence of Radiological Sciences, and Psychiatry at the Geffen School of Medicine, University of California, Los Angeles (UCLA). He is most known for developing novel single voxel based 2D NMR techniques, multi-voxel 2D MRS techniques using hybrid Cartesian as well as non-Cartesian spatio-temporal encoding such as concentric ring, radial and rosette trajectories.